ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

CEFBRAN 100 D/S

Product Packing: 30 ML

Product Composition: Cefixime 100 mg WFI

Product Price: MRP : 65.63

CEFBRAN 100 D/S

Cefixime 100 mg Dry Syrup for Reconstitution with WFI | 30 ml

CEFBRAN 100 D/S is a Cefixime dry syrup formulation supplied for reconstitution with water for injection (WFI) as specified in the product brief. Cefixime is an oral third-generation cephalosporin antibacterial medicine used for selected infections caused by susceptible bacteria according to approved prescribing information.

Cefixime inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins, resulting in impaired peptidoglycan formation and bacterial cell death. It should be used only for bacterial infections where Cefixime is indicated and should not be used for viral illnesses such as the common cold or influenza.

Composition

Each labelled dose contains:

·         Cefixime - 100 mg

·         Dry syrup base / excipients - q.s.

·         For reconstitution with the supplied/approved diluent as directed on the pack. Exact Cefixime strength per 5 ml or other measured volume must be verified from the approved product label.

Dosage form: Dry Syrup for Oral Suspension

Pack size: 30 ml after reconstitution / as per approved pack

Uses of CEFBRAN 100 D/S

CEFBRAN 100 D/S may be prescribed for selected susceptible bacterial infections where oral Cefixime therapy is approved and clinically appropriate.

·         May be used for selected respiratory-tract bacterial infections according to approved indications

·         May be used for selected ear, throat or urinary bacterial infections when caused by susceptible organisms and clinically indicated

·         Provides oral third-generation cephalosporin antibacterial activity

·         Liquid formulation may facilitate accurately measured administration in patients for whom an oral suspension is appropriate

Cefixime does not treat viral infections. Unnecessary or inappropriate antibiotic use contributes to antimicrobial resistance.

How CEFBRAN 100 D/S Works

CEFBRAN 100 D/S contains Cefixime, a third-generation cephalosporin antibacterial:

Cefixime binds to bacterial penicillin-binding proteins involved in cell-wall synthesis.

This inhibits peptidoglycan cross-linking and weakens the bacterial cell wall.

Susceptible bacteria are unable to maintain normal cell-wall integrity, resulting in antibacterial activity.

Effectiveness depends on the infecting organism, susceptibility, site of infection, correctly measured dose and completion of the prescribed course.

Culture and susceptibility testing should be used when clinically appropriate, and antibiotic stewardship principles should guide treatment.

 

Dosage and Direction for Use

Use CEFBRAN 100 D/S exactly as prescribed. Pediatric dosing may depend on body weight, infection type, renal function and the exact Cefixime concentration per measured volume stated on the approved label.

Reconstitute the dry syrup strictly according to the product-specific pack instructions using the specified quantity and type of diluent. Shake well after reconstitution and before each dose.

Measure each dose accurately with a calibrated oral syringe, cup or other appropriate measuring device. Complete the prescribed antibiotic course unless the treating clinician advises otherwise.

Follow the approved storage conditions and in-use period after reconstitution. Discard any remaining suspension after the labelled period.

Possible Side Effects

Possible unwanted effects may include:

·         Diarrhoea, nausea, abdominal discomfort, indigestion or vomiting

·         Headache, dizziness or mild skin rash may occur in some patients

·         Allergic reactions can occur, particularly in patients with a history of beta-lactam allergy

·         Antibiotic-associated diarrhoea, including Clostridioides difficile-associated diarrhoea, can occasionally be serious

·         Seek urgent medical attention for breathing difficulty, facial swelling, severe rash, blistering skin, persistent or bloody diarrhoea, severe weakness or other serious symptoms.

Persistent or troublesome adverse effects should be discussed with a healthcare professional.

Precautions and Contraindications

Before using CEFBRAN 100 D/S, review allergy history, particularly reactions to Cefixime, cephalosporins, penicillins or other beta-lactam antibiotics, as well as kidney function and all concomitant medicines.

·         Serious immediate hypersensitivity reactions require prompt discontinuation and emergency medical management.

·         Renal impairment may require dose adjustment according to current prescribing information.

·         Use antibiotics only for diagnosed or strongly suspected susceptible bacterial infection and avoid unnecessary treatment of viral respiratory illness.

·         Persistent or severe diarrhoea during or after antibiotic treatment requires medical assessment for antibiotic-associated colitis.

·         Prolonged use may permit overgrowth of non-susceptible organisms and should be clinically reviewed.

·         Pregnancy, breastfeeding, infants, children and patients with significant chronic conditions require individualized professional guidance.

·         Keep out of reach of children and store both dry powder and reconstituted suspension according to the approved pack instructions.

·         Drug Interaction Considerations

·         Clinically relevant considerations may include anticoagulants and medicines affecting renal function. Cefixime can also influence certain laboratory tests; current prescribing information should be reviewed where relevant.

·         Patients or caregivers should provide the healthcare professional with a complete list of prescription medicines, OTC products and supplements before treatment.

Business Growth Opportunity with CEFBRAN 100 D/S

CEFBRAN 100 D/S offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Cefixime 100 mg dry syrup in a 30 ml pack to their antibacterial and pediatric-care portfolio.

Oral antibacterial therapy is an established healthcare segment. Promotion and use should remain consistent with approved indications, antimicrobial stewardship, ethical pharmaceutical practice and applicable regulations.

 

Key Business Advantages

·         Third-generation cephalosporin antibacterial formulation

·         Cefixime 100 mg

·         Dry syrup for reconstitution and oral administration

·         Convenient 30 ml pack

·         Suitable addition to antibacterial portfolios where Cefixime is approved and clinically appropriate

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for CEFBRAN 100 D/S

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for CEFBRAN 100 D/S in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for CEFBRAN 100 D/S and other quality-focused healthcare products.

Third-Party Manufacturing Support for Cefixime 100 mg Dry Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to CEFBRAN 100 D/S under their own brand, subject to applicable licensing, antibacterial-product, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized strength, reconstitution and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand an oral antibacterial dry-syrup portfolio.

Frequently Asked Questions About CEFBRAN 100 D/S

1. What is CEFBRAN 100 D/S?

CEFBRAN 100 D/S is a Cefixime 100 mg dry syrup formulation supplied in a 30 ml pack for reconstitution as directed on the approved product label.

2. What is CEFBRAN 100 D/S used for?

It may be prescribed for selected bacterial infections caused by susceptible organisms where Cefixime is approved and clinically appropriate.

3. How should CEFBRAN 100 D/S be prepared?

Reconstitute it only according to the product-specific pack instructions using the specified quantity and type of diluent, then shake well. Do not guess the reconstitution volume.

4. How should the reconstituted suspension be measured?

Use a calibrated oral measuring device and follow the exact prescribed volume based on the approved Cefixime concentration.

5. Does Cefixime treat viral colds or flu?

No. Cefixime is an antibacterial medicine and does not treat viral infections such as the common cold or influenza.

6. What important precautions apply to Cefixime?

Important precautions include beta-lactam allergy, kidney impairment, serious or persistent diarrhoea and appropriate antibiotic stewardship.

7. Is a PCD Pharma Franchise available for CEFBRAN 100 D/S?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Cefixime dry syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

CEFBRAN 100 D/S product information in this document is for general professional and business information. The supplied product brief states Cefixime 100 mg, WFI, DRY SYP 30 ML, but does not specify whether 100 mg applies per 5 ml or another measured volume, nor the exact WFI/reconstitution quantity. These details have therefore not been inferred. Exact composition, concentration after reconstitution, diluent instructions, approved age range, indications, dosage, contraindications, warnings, interactions, storage after reconstitution and regulatory status must be verified against the current approved product label before manufacture, promotion, prescribing, dispensing or use. Antibiotics should be used responsibly for appropriate bacterial infections. This document is not a substitute for professional medical advice.

Contact